leftspacer middlespacer rightspacer
Media Menu
Email Newsletter Archive

MAPS BULLETIN
MAPS Bulletin Summer 2014: Research Edition
 
Media > Newsletter: May 4, 2010



Psychedelic Science in NY Times, CNN, USA Today, BBC, NPR, Scientific American, and more!
MAPS mission is to treat conditions for which conventional medicines provide limited relief, such as PTSD & anxiety associated with life-threatening illnesses, by developing psychedelics & marijuana into prescription medicines.
Psychedelic Science in NY Times, CNN, USA Today, BBC, NPR, Scientific American, and more!
May 4, 2010

Dear MAPS Members and Supporters,

We’re proud to report that our conference, Psychedelic Science in the 21st Century, was a magnificent success! We generated a spectacular amount of media as a result, including from CNN, MSNBC, BBC, NPR, Scientific American, Nature News, New York Times, USA Today and many other media outlets. We have archived the conference related media reports on both our MAPS in the Media page and Psychedelic Science in the 21st Century page. We predict that the astonishingly positive public education achieved by these articles will be seen in retrospect as a turning point, building public support for a substantial expansion of psychedelic research. We encourage you to review and share these media reports with your friends and family.

In case you missed it, or you’d like to see it again, here is the 19 minute opening talk by MAPS Executive Director Rick Doblin, Ph.D. (if the video does not appear in your email, you can watch it at this link): http://www.vimeo.com/11447375

At the conference we distributed our new MDMA/PTSD drug development prospectus, describing MAPS’ Phase 2 pilot studies to be conducted over the next three years, leading to an "end-of-phase 2 meeting" with the U.S. FDA and the European Medicines Agency (EMEA). Please read the prospectus and make a contribution to MAPS today to partner with us in our multinational MDMA/PTSD research.

We at MAPS wish to extend our warmest gratitude to our sister organizations -- the Heffter Research Institute, the Beckley Foundation, and the Council on Spiritual Practices -- for collaborating with us and making the conference a huge success. The conference was a momentous occasion, with over 1200 people in attendance. Hundreds more people were turned away due to limited capacity. The conference was one of the most outstanding occurrences in all of MAPS 24 years of existence.

Together, we can further the expansion and integration of psychedelic science in the 21st century!

Sincerely,

Randolph Hencken, M.A.
Director of Communication and Marketing, MAPS

twitter icon Sign up for our twitter feed and get instant updates from Executive Director Rick Doblin, Ph.D. and other MAPS staff.


50 limited-edition, signed and numbered prints of Ann and Alexander "Sasha" Shulgin by Alex Grey

On Saturday, April 17, during the Shulgin tribute dinner, Alex Grey unveiled his newest portrait of Ann and Sasha Shulgin. Fifty numbered limited edition prints of this portrait, signed by Alex, Sasha, and Ann are available through the MAPS webstore. Prices vary from $1500 to $3500, depending on the number (#1 sold at auction for $6600). Proceeds will be split between MAPS’ MDMA/PTSD research with veterans of war and Alex and Allyson Grey’s Chapel of Sacred Mirrors, with an honorarium being given to Ann and Sasha. Weve already sold almost half the prints, so act quickly if you want one.

Shulgin Tribute Dinner

The banquet hall at Psychedelic Science in the 21st Century during the Ann and Sasha Shulgin tribute dinner.


Psychedelic Science in the 21st Century from Teal Sievers on Vimeo.

Rick’s Opening Address

MAPS Executive Director Rick Doblin, Ph.D. addresses a full house at Psychedelic Science in the 21st Century.



MAPS 309 Cedar Street #2323 Santa Cruz, CA 95060-9989 tel: 831-429-MDMA (6362) fax: 831-429-6370
MAPS Website Join MAPS
rss feed icon youtube icon myspace icon facebook icon twitter icon
Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.